Oncoloxía radioterápica

2023

1. (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

   International Journal of Cancer, Vol. 153, Núm. 9, pp. 1579-1591

2. CBCT dose distribution calculation with GATE Monte Carlo simulations for lymphoma patients

   Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Vienna, AUSTRIA, MAY 12-16, 2023

3. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

   Radiotherapy and Oncology, Vol. 187

4. Hypofractionated and Intensified Radiotherapy for nonsurgical Glioblastoma Multiforme

   Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)

5. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

   Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

6. Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

   JNCI Cancer Spectrum, Vol. 7, Núm. 6

7. Radiation Therapy for Metastatic Lung Cancer: Bone Metastasis and Metastatic Spinal Cord Compression

   Medical Radiology (Springer Science and Business Media Deutschland GmbH), pp. 779-793

8. Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry

   EJNMMI Physics, Vol. 10, Núm. 1

9. Radiogenomics in lung cancer: Where are we?

   Lung Cancer, Vol. 176, pp. 56-74

10. Reply to: Comments on “(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer”

    International Journal of Cancer

11. Stereotactic body radiation therapy for kidney cancer. Where do we stand?

    International Journal of Urology, Vol. 30, Núm. 5, pp. 437-445

12. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review

    Future oncology (London, England), Vol. 19, Núm. 25, pp. 1753-1768